ArticleClinical and experimental immunology1986
Presence of factors chemotactic for granulocytes in hypereosinophilic syndrome sera: relation with alterations in eosinophil migration.
Article in Clinical and experimental immunology, 1986. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 15 citations in OpenAlex.
- Presence of antibodies against endothelial cells in the sera of patients with episodic angioedema and hypereosinophilia.Clinical and experimental immunology · 1990Article
- Heterogeneity of human eosinophil glucocorticoid receptor expression in hypereosinophilic patients: absence of detectable receptor correlates with resistance to corticotherapy.Clinical and experimental immunology · 1989Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent work has underlined a structural and metabolic heterogeneity amongst blood eosinophils in various hypereosinophilic diseases. Little is known about the factors responsible for this variability. We have identified granulocyte chemotactic factors, termed GCFs in the sera of five patients with hypereosinophilic syndrome (HES). Sera from normal controls or from 20 patients with blood hypereosinophilia of various causes, but with little or no hypodense blood eosinophils, did not demonstrate any chemotactic activity. Two distinct GCFs were characterized, either by gel filtration or isoelectric focusing (molecular weights of 600 kD and 240 kD; pIs of approximately 5 and 7). These fractions are sensitive to proteolytic enzymes and to heating to 100 degrees C but not to 56 degrees C. The activity of GCFs has been tested towards neutrophils and eosinophils. The fractions of 240 kD and pI 7 appear more selective for the eosinophil lineage. Checkerboard analysis shows that such fractions are primarily chemotactic. In addition, hypodense eosinophils appear defective in random motility and chemotaxis towards chemotactic agents which are effective on normodense eosinophils. Moreover, preincubation of normodense eosinophils with HES sera rendered these cells unresponsive to very efficient chemotactic agents such as leukotriene B4 (LTB4) (decrease in migration of 91%; P less than 10(-3), formyl methionyl leucyl phenylalanyl (Fmlp) (decrease of 95%; P less than 10(-2)), HES sera (decrease of 91 to 93%). These findings suggest a process of deactivation of blood eosinophils with the possible retention within the circulation of activated hypodense eosinophils in HES.
Indexed as
Identifiers
3780047PMC1542502W138692764What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.